Eyal Kalanthroff, PhD

JCP
Letter to the Editor

April 26, 2017

Reports have indicated that a single intravenous ketamine dose rapidly decreases OCD symptoms. These researchers planned a study of nasal ketamine administration for this purpose, but they quickly encountered...
Carolyn I. Rodriguez, Kyle A. B. Lapidus, Jordana Zwerling, et al

Celebrating
85 Years

Read the Journal of Clinical Psychiatry

Subscribe to read
more articles

Subscribe